Icon

QBRELIS (nda208401)- (1MG/ML)

LISINOPRIL AZURITY
1MG/ML
Yes Yes
2035-Nov-06 Expired
None None
None No
QBRELIS is an angiotensin converting enzyme (ACE) inhibitor indicated for: • Treatment of hypertension in adults and pediatric patients 6 years of age and older • Adjunct therapy for heart failure • Treatment of Acute Myocardial Infarction
0 0 0
Total Other Developers 1
Drugs with Suitability No
1MG/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.